Additionally, Gal-1 could enhance the immune cell evasion of pancreatic tumors by hampering T-cell and neutrophil tumor infiltration but whether GLI1 mediated this effect remains to be elucidated. The gene discussed is GLI1; the disease is pancreatic neoplasm.